Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

ClearLight Biotechnologies

ClearLight Biotechnologies
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$2.77M LATEST DEAL AMOUNT
6 INVESTORS
Description

Developer of a next generation tissue processing and imaging technology aimed at revolutionizing cancer treatment. The company's technology provides a suite of powerful tools, with deep 3-D imaging, which will allow the measurement of important spatial relationships between different cell types, vasculature and nucleic acids within the tumor and surrounding tissue and provides high-resolution information from solid tumors, while maintaining the global perspective needed to understand the complex tumor microenvironment, enabling better treatment decisions for patients.

Formerly Known As
ClearLight Diagnostics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Primary Office
  • 428 Oakmead Parkway
  • Sunnyvale, CA 94085
  • United States

+1 (800) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore ClearLight Biotechnologies’s full profile, request a free trial.

ClearLight Biotechnologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 08-May-2018 $2.77M 000.00 Completed Product Development
3. Later Stage VC (Series C) 0000 000.00 Completed Startup
2. Early Stage VC (Series B) 03-Oct-2016 $3.5M $6.08M Completed Startup
1. Early Stage VC (Series A) 08-Oct-2015 $2.58M $2.58M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

ClearLight Biotechnologies Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
CS Investors Corporation Minority 000 0000 000000 0
KESA Partners Merchant Banking Firm Minority 000 0000 000000 0
Nan Fung Life Sciences Venture Capital Minority 000 0000 000000 0
Pivotal Paramount Investment Other Minority 000 0000 000000 0
Stanford University Venture Fund Other Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

ClearLight Biotechnologies Executive Team (4)

Name Title Board
Seat
Contact
Info
Laurie Goodman Ph.D Chief Executive Officer & Board Member
Maria Hurst Director of Operations
Karl Deisseroth MD Founder & Scientific Advisor

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

ClearLight Biotechnologies Board Members (5)

Name Representing Role Since Contact
Info
Albert Hansen KESA Partners Vice Chairman 000 0000
Alexander Wiegers Wiegers Capital Management Chairman 000 0000
Laurie Goodman Ph.D ClearLight Biotechnologies Chief Executive Officer & Board Member 000 0000

2 Former Board Members

You’re viewing 3 of 5 board members. Get the full list »